Search

everythinglearnresearchcommunity

for

Search:↓

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Possible link between COVID-19 and hair loss; more research needed.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The link between anabolic agents and colorectal cancer risk is unclear.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Testosterone may influence COVID-19 severity and outcomes.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Bone mineral and minocycline boost bone cell growth, aiding healing.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.